research

First Opinion Uzma Rentia

I’m a fourth-year med student, but I only learned one historical example of medical racism

Exclusive Megan Molteni

STAT Plus: Integrative medicine practitioner and wife of acting U.S. attorney general appointed to NIH advisory council

Biotech Elaine Chen, Damian Garde, and Daniel Payne

STAT Plus: FDA to speed up review of three psychedelics as mental health treatments

The Readout Meghana Keshavan

STAT Plus: Sanofi MS drug gets positive review in Europe following FDA

In the Lab Anil Oza

Growing use of guest editors has turned some journals into a ‘playground of bad science’

In the Lab Anil Oza

Heart’s beat may help it beat cancer, mouse research suggests

Health Lev Facher

STAT Plus: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy

The Readout Meghana Keshavan

STAT Plus: Sanofi research priorities in flux as new CEO logs in 

Health Theresa Gaffney

Increased calls to 988 hotline associated with a drop in suicides among young people, study finds

The Readout Elaine Chen

STAT Plus: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy

Biotech Angus Chen

STAT Plus: From Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it

Politics Chelsea Cirruzzo

STAT Plus: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS

The Readout Elaine Chen

STAT Plus: Kelonia Therapeutics’ road from floundering to $3 billion

Biotech Angus Chen

STAT Plus: In early trial, CAR-T results raise hope of preventing multiple myeloma in high-risk patients

The Readout Meghana Keshavan

STAT Plus: Finally cracking KRAS as a druggable target

Pharmalot Ed Silverman

STAT Plus: A controversy over research monkeys highlights ambiguity over health standards

Special Report Angus Chen

STAT Plus: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades

The Readout Meghana Keshavan

STAT Plus: FDA eyes expanding testosterone therapy for libido

The Readout Meghana Keshavan

STAT Plus: Cochrane review reignites Alzheimer’s amyloid wars

The Readout Elaine Chen

STAT Plus: Novartis CEO joins Anthropic’s board

The Readout Elaine Chen

STAT Plus: FDA pressures drugmakers to report trial results

The Readout Meghana Keshavan

STAT Plus: GSK advancing ovarian cancer drug mo-rez

The Readout Meghana Keshavan

STAT Plus: A new trick for old science, and biotech VCs’ scrambled playbook

The Readout Meghana Keshavan

STAT Plus: Genetics may shape GLP-1 outcomes, slightly

First Opinion Chirantan Chatterjee and Guy Vernet

The Pasteur Institute of Iran illustrates important truths about global public health

First Opinion David S. Ludwig

Tastiness is not why people overeat

Politics Megan Molteni

STAT Plus: Trump administration drops court fight to cap NIH payments for research overhead costs

In the Lab Annalisa Merelli

Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests

The Readout Elaine Chen

STAT Plus: Terns’ drug may not be as competitive as many initially thought